HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideoki Ogawa Selected Research

Lipopolysaccharides

1/2017Ceramide-CD300f Binding Inhibits Lipopolysaccharide-induced Skin Inflammation.
1/2009Transforming growth factor-beta activity in commercially available pasteurized cow milk provides protection against inflammation in mice.
1/2006Human defensins and cathelicidins in the skin: beyond direct antimicrobial properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideoki Ogawa Research Topics

Disease

47Inflammation (Inflammations)
11/2023 - 04/2002
40Atopic Dermatitis (Atopic Eczema)
02/2024 - 03/2002
28Hypersensitivity (Allergy)
11/2023 - 05/2002
19Infections
12/2023 - 12/2002
17Wounds and Injuries (Trauma)
02/2024 - 03/2003
14Rheumatoid Arthritis
01/2017 - 01/2007
13Psoriasis (Pustulosis Palmaris et Plantaris)
02/2024 - 12/2002
13Dermatitis
05/2023 - 04/2012
13Asthma (Bronchial Asthma)
01/2016 - 08/2002
12Pruritus (Itching)
02/2021 - 04/2002
9Food Hypersensitivity (Food Allergy)
01/2023 - 06/2005
9Skin Diseases (Skin Disease)
11/2017 - 12/2002
8type 2C Congenital disorder of glycosylation
01/2022 - 04/2010
7Eosinophilia
01/2024 - 11/2009
7Anaphylaxis (Anaphylactic Shock)
01/2023 - 06/2005
6Neoplasms (Cancer)
02/2022 - 09/2002
5Allergic Rhinitis
04/2024 - 03/2002
5Arthritis (Polyarthritis)
01/2019 - 01/2007
5Virus Diseases (Viral Diseases)
01/2018 - 01/2009
4Allergic Conjunctivitis (Giant Papillary Conjunctivitis)
11/2023 - 02/2009
4Hyperplasia
03/2017 - 02/2007
4Necrosis
01/2009 - 03/2004
4Ulcer
11/2007 - 09/2006
3Seasonal Allergic Rhinitis (Hay Fever)
11/2023 - 03/2008
3Contact Dermatitis (Eczema, Contact)
01/2022 - 09/2010
3Melanoma (Melanoma, Malignant)
03/2015 - 07/2010
3Blister (Bulla)
12/2014 - 05/2007
3Colitis
01/2014 - 01/2009
3Bacterial Infections (Bacterial Infection)
07/2013 - 11/2005
3Tinea (Ringworm)
07/2011 - 01/2003
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2011 - 10/2007
3Atherosclerosis
12/2008 - 12/2007
3Skin Ulcer
11/2007 - 09/2005
3Keloid
03/2007 - 06/2003
3Tinea Pedis (Athlete's Foot)
01/2007 - 05/2006
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2005 - 09/2002
2Diarrhea
01/2023 - 03/2017

Drug/Important Bio-Agent (IBA)

31CytokinesIBA
05/2023 - 05/2002
25Immunoglobulin E (IgE)IBA
04/2024 - 04/2002
24AllergensIBA
11/2023 - 07/2005
19Proteins (Proteins, Gene)FDA Link
02/2024 - 07/2003
16AntigensIBA
01/2024 - 02/2004
16Transforming Growth Factor beta (TGF-beta)IBA
09/2010 - 08/2002
12Peptide Hydrolases (Proteases)FDA Link
01/2024 - 03/2008
11ChemokinesIBA
01/2022 - 12/2002
11Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 02/2003
10Thymic Stromal LymphopoietinIBA
06/2012 - 05/2007
8LigandsIBA
12/2015 - 09/2007
7Peptides (Polypeptides)IBA
01/2022 - 09/2003
7Immunoglobulin G (IgG)IBA
01/2021 - 06/2006
7EnzymesIBA
06/2015 - 09/2002
6PapainIBA
01/2024 - 05/2013
6Interleukin-33IBA
05/2023 - 05/2013
6Antimicrobial PeptidesIBA
03/2023 - 12/2005
6Tacrolimus (Prograf)FDA LinkGeneric
04/2017 - 02/2002
6Dermatophagoides pteronyssinus antigen p 1IBA
12/2011 - 07/2005
5OvalbuminIBA
01/2021 - 02/2004
5Connective Tissue Growth FactorIBA
02/2018 - 01/2009
5Interleukin-13IBA
05/2013 - 10/2003
4CeramidesIBA
04/2024 - 01/2014
4Interleukin-4 (Interleukin 4)IBA
01/2022 - 10/2003
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 06/2007
4Imiquimod (Aldara)FDA LinkGeneric
02/2018 - 12/2005
4Ointments (Pastes)IBA
04/2017 - 04/2005
4IgE Receptors (Fc epsilon RI)IBA
04/2016 - 11/2004
4Tretinoin (Retinoic Acid)FDA LinkGeneric
03/2015 - 08/2007
4Collagen Type II (Type II Collagen)IBA
06/2013 - 01/2007
4Dermatophagoides farinae antigen f 1IBA
05/2013 - 07/2005
4Messenger RNA (mRNA)IBA
09/2012 - 10/2003
3LipidsIBA
01/2022 - 07/2007
3ProstaglandinsIBA
01/2021 - 09/2003
3Bromodeoxyuridine (BrdU)IBA
09/2020 - 02/2007
3CathelicidinsIBA
11/2017 - 12/2005
3Petrolatum (Vaseline)FDA Link
04/2017 - 03/2002
3LipopolysaccharidesIBA
01/2017 - 01/2006
3AntipruriticsIBA
12/2016 - 12/2014
3Semaphorin-3AIBA
11/2015 - 07/2009
3Dextrans (Dextran)FDA Link
01/2014 - 01/2009
3sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2014 - 01/2009
3Yi-Gan SanIBA
01/2014 - 10/2009
3Gonadal Steroid Hormones (Sex Hormones)IBA
10/2012 - 10/2007
3Nerve Growth Factor (NGF)IBA
08/2011 - 06/2007
3Transforming Growth Factor-beta Type I ReceptorIBA
09/2010 - 07/2005
3Phosphotransferases (Kinase)IBA
09/2010 - 07/2005
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2010 - 01/2007
3ImmunosorbentsIBA
06/2009 - 01/2007
3CollagenIBA
03/2007 - 06/2003
3Anti-Bacterial Agents (Antibiotics)IBA
09/2006 - 11/2005
2MannansIBA
12/2023 - 01/2022
2Detergents (Detergent)IBA
11/2023 - 01/2022
2InterleukinsIBA
05/2023 - 01/2015
2TropomyosinIBA
01/2023 - 04/2017
2S100 Calcium Binding Protein A7IBA
02/2022 - 07/2008
2DNA (Deoxyribonucleic Acid)IBA
02/2022 - 12/2004
2ragweed pollenIBA
01/2022 - 09/2009

Therapy/Procedure

18Therapeutics
03/2017 - 12/2002
5Oral Administration
10/2009 - 06/2005
4Lasers (Laser)
02/2009 - 09/2006
3Immunotherapy
01/2021 - 01/2009
2Intranasal Administration
04/2024 - 05/2013